Literature DB >> 10819370

Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open "coliseum technique".

J Esquivel1, F Angulo, R K Bland, A D Stephens, P H Sugarbaker.   

Abstract

BACKGROUND: Heated intraoperative intraperitoneal chemotherapy achieves high peritoneal concentrations with limited systemic absorption and has become an important tool in the management of patients with peritoneal carcinomatosis from low-grade malignancies such as pseudomyxoma peritonei and in selected cases of high-grade tumors such as colon adenocarcinoma. When the closed abdomen technique is used, its perioperative toxicity seems to be related to the hemodynamic and cardiac function changes associated with increased body temperature and increased intra-abdominal pressure.
METHODS: Hemodynamic and cardiac function variables during heated intraoperative intraperitoneal chemotherapy, using an open abdomen "coliseum technique," were measured in 15 patients with the use of a noninvasive esophageal Doppler monitor.
RESULTS: The hemodynamic and cardiac function changes were characterized by an increased heart rate, increased cardiac output and decreased systemic vascular resistance associated with an increased body temperature, and decreased effective circulating volume with the urinary output tending to decrease as the therapy progressed.
CONCLUSION: Heated intraoperative intraperitoneal chemotherapy with the open abdomen coliseum technique induces a hyperdynamic circulatory state with an increased intravenous fluid requirement and avoids changes because of increased intra-abdominal pressure. Hemodynamic and cardiac stability, as documented by normal blood pressure and adequate urinary output, can be achieved by liberal intravenous fluids, titrated to frequent urinary output determination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10819370     DOI: 10.1007/s10434-000-0296-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  26 in total

1.  A randomized trial of goal directed vs. standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  Luca Colantonio; Claudia Claroni; Luana Fabrizi; Maria Elena Marcelli; Maria Sofra; Diana Giannarelli; Alfredo Garofalo; Ester Forastiere
Journal:  J Gastrointest Surg       Date:  2015-01-17       Impact factor: 3.452

Review 2.  Anaesthetic Considerations in the Perioperative Management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Deepak B Sheshadri; Murali R Chakravarthy
Journal:  Indian J Surg Oncol       Date:  2016-02-20

3.  A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.

Authors:  Stephanie Downs-Canner; Ying Ding; Deepa R Magge; Heather Jones; Lekshmi Ramalingam; Amer Zureikat; Matthew Holtzman; Steven Ahrendt; James Pingpank; Herbert J Zeh; David L Bartlett; Haroon A Choudry
Journal:  Ann Surg Oncol       Date:  2014-10-28       Impact factor: 5.344

4.  Hemodynamic Monitoring During Heated Intraoperative Intraperitoneal Chemotherapy Using the FloTrac/Vigileo System.

Authors:  Christos Mavroudis; Leonidas Alevizos; Konstantinos M Stamou; Theodosia Vogiatzaki; Savvas Eleftheriadis; Odysseas Korakianitis; Antonios A Tentes; Christos Iatrou
Journal:  Int Surg       Date:  2015-01-15

5.  Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations.

Authors:  Ning Miao; James F Pingpank; H Richard Alexander; Richard Royal; Seth M Steinberg; Martha M Quezado; Tatiana Beresnev; Zenaide M N Quezado
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

Review 6.  Intensive Care Management of Patient After Cytoreductive Surgery and HIPEC - A Concise Review.

Authors:  A V Padmakumar
Journal:  Indian J Surg Oncol       Date:  2016-02-18

7.  Inflammatory response and optimalisation of perioperative fluid administration during hyperthermic intraoperative intraperitoneal chemotherapy surgery.

Authors:  Piet de Witte; Christien A de Witt; Johan L van de Minkelis; Djamila Boerma; H Frank Solinger; C Erik Hack; Peter Bruins
Journal:  J Gastrointest Oncol       Date:  2019-04

8.  The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  Raphael Shamavonian; Rohan McLachlan; Oliver M Fisher; Sarah J Valle; Nayef A Alzahrani; Winston Liauw; David L Morris
Journal:  J Gastrointest Oncol       Date:  2019-04

9.  Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Oliver S Eng; Sinziana Dumitra; Michael O'Leary; Mustafa Raoof; Mark Wakabayashi; Thanh H Dellinger; Ernest S Han; Stephen J Lee; I Benjamin Paz; Byrne Lee
Journal:  JAMA Surg       Date:  2017-12-01       Impact factor: 14.766

10.  Pulmonary influences on early post-operative recovery in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: a retrospective study.

Authors:  Erebouni Arakelian; Michael R Torkzad; Antonina Bergman; Sten Rubertsson; Haile Mahteme
Journal:  World J Surg Oncol       Date:  2012-11-27       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.